Central Pacific Bank - Trust Division’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.66M Sell
7,222
-2,231
-24% -$2.28M 0.88% 19
2026
Q1
$8.69M Buy
9,453
+680
+8% +$689K 1.11% 11
2025
Q4
$9.43M Sell
8,773
-217
-2% -$207K 1.16% 9
2025
Q3
$6.86M Buy
8,990
+1,843
+26% +$1.37M 0.83% 18
2025
Q2
$5.57M Sell
7,147
-339
-5% -$263K 0.71% 22
2025
Q1
$6.18M Buy
7,486
+1,027
+16% +$855K 0.86% 15
2024
Q4
$4.99M Sell
6,459
-4,105
-39% -$3.4M 0.65% 23
2024
Q3
$9.36M Sell
10,564
-776
-7% -$698K 1.18% 10
2024
Q2
$10.3M Sell
11,340
-749
-6% -$599K 1.22% 10
2024
Q1
$9.19M Buy
+12,089
New +$8.6M 1.14% 8

Other funds holding LLY

Central Pacific Bank - Trust Division's LLY Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $2.28M and leaving 7,222 shares worth $8.66M. The position accounts for 0.88% of the portfolio, ranked #19.

Central Pacific Bank - Trust Division first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.3M in Q2 2024. 2,232 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Central Pacific Bank - Trust Division held 7,222 shares of Eli Lilly worth $8.66M as of Q2 2026.
  • Central Pacific Bank - Trust Division sold 2,231 Eli Lilly shares in Q2 2026, an estimated $2.28M.
  • Eli Lilly made up 0.88% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #19 holding.
  • Central Pacific Bank - Trust Division first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Eli Lilly position peaked at $10.3M in Q2 2024.
  • 2,232 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.